Discussion with John Ojal: Cost-Effectiveness of Sustaining Kenya's PCV Program

Research Brief, April 2019.

DOWNLOAD MP4

Summary

As their economies grow and they transition out of Gavi financial support, many low-income countries will need to consider the value of continuing their previously-subsidized vaccine programs at full cost. Using Kenya as a case example, the PCVIS team recently assessed the cost-effectiveness. Lead study author John Ojal discusses the study and its policy implications for Kenya and similar countries transitioning from Gavi support.